Justin Maykel to Adenocarcinoma
This is a "connection" page, showing publications Justin Maykel has written about Adenocarcinoma.
Connection Strength
1.791
-
Maykel JA. Laparoscopic Transanal Total Mesorectal Excision (taTME) for Rectal Cancer. J Gastrointest Surg. 2015 Oct; 19(10):1880-8.
Score: 0.360
-
Davids JS, Alavi K, Andres Cervera-Servin J, Choi CS, Sturrock PR, Sweeney WB, Maykel JA. Routine preoperative restaging CTs after neoadjuvant chemoradiation for locally advanced rectal cancer are low yield: a retrospective case study. Int J Surg. 2014 Dec; 12(12):1295-9.
Score: 0.344
-
Maykel JA, Hagerman G, Mellgren AF, Li SY, Alavi K, Baxter NN, Madoff RD. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients. Dis Colon Rectum. 2006 Jul; 49(7):950-7.
Score: 0.193
-
Hu A, Gallant B, Reddington H, Ballinger Z, Maykel J, Aulet T, Sturrock P, Peponis T, Lou F, Alavi K. Robotics on the rise, but not everywhere: National trends in robotic approach for colorectal cancer surgery. J Gastrointest Surg. 2026 Aug; 30(8):102424.
Score: 0.190
-
Tuynman JB, Yao H, Moolenaar LR, Sietses C, Hompes R, Aigner F, Caycedo-Marulanda A, Chen CC, Deeb M, Doornebosch PG, Feng B, Foo CC, F?rst A, Ito M, de Lacy FB, Le?o P, Maykel JA, Muratore A, van Oostendorp SE, Park SC, Pedziwiatr M, Ren M, Seitinger G, Stockmann HBAC, Talsma AK, T?rler A, Tong W, Wang Q, Xu Q, Zhang H, van Waesberghe JTM, Ali M, Twisk JWR, Zhang Z, de Lacy AM, Hanna GB, Bonjer HJ. Transanal total mesorectal excision versus laparoscopic total mesorectal excision for mid and low rectal cancer (COLOR III): short-term outcomes of an international, multicentre, phase 3, randomised, controlled, non-inferiority trial. Lancet Gastroenterol Hepatol. 2026 May; 11(5):355-366.
Score: 0.189
-
Donovan KF, Carmichael H, Chadi S, Ricardo A, Bonaccorso A, Tomada EP, Sands D, Marks J, Maykel J, Alavi K, Zaghiyan K, Whiteford M, McLemore EC, Shawki SF, Steele S, Pigazzi A, Albert M, DeBeche-Adams T, Avery L, Wexner S, Sylla P. Long-term Results of the North American Phase II Transanal Total Mesorectal Excision Multicenter Trial for Rectal Cancer. Ann Surg. 2026 Aug 01; 284(2):236-243.
Score: 0.189
-
Zewde MG, Peyser DK, Yu AT, Bonaccorso AM, Moshier EL, Alavi K, Goldstone RN, Marks JH, Maykel JA, McLemore EC, Sands DR, Steele SR, Wexner SD, Whiteford MH, Sylla P. Impact of Obesity on Postoperative Outcomes in Transanal Total Mesorectal Excision for Rectal Cancer. Dis Colon Rectum. 2026 04 01; 69(4):553-564.
Score: 0.186
-
Hill SS, Chung SK, Meyer DC, Crawford AS, Sturrock PR, Harnsberger CR, Davids JS, Maykel JA, Alavi K. Impact of Preoperative Care for Rectal Adenocarcinoma on Pathologic Specimen Quality and Postoperative Morbidity: A NSQIP Analysis. J Am Coll Surg. 2020 01; 230(1):17-25.
Score: 0.121
-
Walker AS, Nelson DW, Fowler JJ, Causey MW, Quade S, Johnson EK, Maykel JA, Steele SR. An evaluation of colonoscopy surveillance guidelines: are we actually adhering to the guidelines? Am J Surg. 2013 May; 205(5):618-22; discussion 622.
Score: 0.019